102
Views
5
CrossRef citations to date
0
Altmetric
Articles

Systemic vascular resistance and endogenous inhibitors of nitric oxide synthesis in early- compared to late-onset preeclampsia: preliminary findings

, , , , , & show all

References

  • American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in Pregnancy. 2013. Accessed http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy
  • Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. NICE clinical guideline 107. Accessed http://www.nice.org.uk/guidance/cg107/evidence/full-guideline-134794333
  • Duley L. The global impact of preeclampsia and eclampsia. Semin Perinatol. 2009;33:130–37. doi:10.1053/j.semperi.2009.02.010.
  • Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–44. doi:10.1016/S0140-6736(10)60279-6.
  • Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391–93. doi:10.1016/j.bpobgyn.2011.01.006.
  • Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, et al. Predictive value of the sFlt-1: PlGFRatio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22. doi:10.1056/NEJMoa1414838.
  • Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–75. doi:10.1161/HYPERTENSIONAHA.107.107607.
  • Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–48. doi:10.1081/PRG-120021060.
  • Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:40–49. doi:10.1016/j.ajog.2005.07.049.
  • Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873–80. doi:10.1161/HYPERTENSIONAHA.108.117358.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209:544.e1–544.e12. doi:10.1016/j.ajog.2013.08.019.
  • Li XL, Guo PL, Xue Y, Gou WL, Tong M, Chen Q. An analysis of the differences of early and late preeclampsia with severe hypertension. Pregnancy Hypertens. 2016;6:47–52.
  • Shi J, Yang Z, Chen L. Study on the heterogeneity of edema in severe preeclampsia. Zonghua Yi Xue Za Zhi. 2014;94:1342–45.
  • Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens. 2013;3:44–47.
  • Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66:497–506. doi:10.1097/OGX.0b013e3182331028.
  • Khaw A, Kametas NA, Turan OM, Bamfo JE, Nicolaides KH. Maternal cardiac function and uterine artery Doppler at 11 – 14 weeks in the prediction of pre-eclampsia in nulliparous women. BJOG. 2008;115:369–76. doi:10.1111/j.1471-0528.2007.01577.x.
  • Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:978–84.
  • Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol. 1990;76:1061–69.
  • Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH. Maternal cardiac function at 35-37 weeks’ gestation: prediction of pre-eclampsia and gestational hypertension. Ultrasound Obstet Gynecol. 2017;49:61–66. doi:10.1002/uog.2017.49.issue-1.
  • Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272:R441–63.
  • Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002;283: R29–45.
  • Conrad KP, Joffe GM, Kruszyna H, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566–71.
  • Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994;91:5212–16. doi:10.1073/pnas.91.11.5212.
  • Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994;171:944–48. doi:10.1016/S0002-9378(94)70064-8.
  • Barton JR, Sibai BM, Ahokas RA, Whybrew WD, Mercer BM. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol. 1992;167:931–34. doi:10.1016/S0002-9378(12)80014-7.
  • Cameron IT, van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy. 1993;12:85–92. doi:10.3109/10641959309031055.
  • Ne C, Nm G, Rg K, Pj M, Tj R, Brennecke SP. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Pregnancy. 1995;14:339–49. doi:10.3109/10641959509015680.
  • Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet. 1993;342:242–43. doi:10.1016/0140-6736(93)92335-Q.
  • Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1998;178:551–56. doi:10.1016/S0002-9378(98)70437-5.
  • Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand. 1998;77:808–13. doi:10.1080/j.1600-0412.1998.770805.x.
  • Speer PD, Powers RW, Frank MP, Harger G, Markovic N, Roberts JM. Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol. 2008;198:112.e1–7. doi:10.1016/j.ajog.2007.05.052.
  • Bode-Böger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, Reinecke H. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol. 2006;17:1128–34. doi:10.1681/ASN.2005101119.
  • Fortin J, Habenbacher W, Heller A, Hacker A, Grüllenberger R, Innerhofer J, et al. Non-invasive beat-to-beat cardiac output monitoring by an improved method of transthoracic bioimpedance measurement. Comput Biol Med. 2006;36:1185–203. doi:10.1016/j.compbiomed.2005.06.001.
  • Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH. Development and evaluation of an impedance cardiac output system. Aerosp Med. 1996;37:1208–12.
  • DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Medicine. 1916;17:863–71. doi:10.1001/archinte.1916.00080130010002.
  • Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth. 1992;4:4–10. doi:10.1016/0952-8180(92)90111-D.
  • Weber TM, Lackner HK, Roessler A, Papousek I, Kolovetsiou-Kreiner V, Lucovnik M, Schmid-Zalaudek K, Lang U, Moertl MG. Heart rate variability and baroreceptor reflex sensitivity in early- versus late-onset preeclampsia. 2017.
  • Belford MA, Rokey R, Saade GR, et al. Rapid echocardiographic assessment of left and right heart hemodynamics in critically ill obstetric patients. Am J Obstet Gynecol. 1994;171:884–92. doi:10.1016/S0002-9378(94)70055-9.
  • Belford MA, Mares A, Saade GR, et al. Two-dimensional echocardiography and Doppler ultrasound in managing obstetric patients. Obstet Gynecol. 1997;90:326–30. doi:10.1016/S0029-7844(97)00282-2.
  • Moertl MG, Schlembach D, Papousek I, Hinghofer-Szalkay H, Weiss EM, Lang U, Lackner HK. Hemodynamic evaluation in pregnancy: limitations of impedance cardiography. Physiol Meas. 2012;33:1015–26. doi:10.1088/0967-3334/33/6/1015.
  • Kager CC, Dekker GA, Stam MC. Measurement of cardiac output in normal pregnancy by a non-invasive two-dimensional independent Doppler device. Aust N Z J Obstet Gynaecol. 2009;49:142–44. doi:10.1111/j.1479-828X.2009.00948.x.
  • Vinayagam D, Patey O, Thilaganathan B, Khalil A. Cardiac output assessment in pregnancy: comparison of two automated monitors with echocardiography. Ultrasound Obstet Gynecol. 2017;49:32–38. doi:10.1002/uog.2017.49.issue-1.
  • Poorolajal J, Jenabi E. The association between body mass index and preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29:3670–76. doi:10.3109/14767058.2016.1140738.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.